Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy - Ziegler, D; Hanefeld, M; Ruhnau, KJ; Hasche, H; Lobisch, M; Schutte, K (Diabetes Care, 1999)
et al.